Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis
Publication
, Journal Article
Lynd, LD; Colley, L; Najafzedeh, M; Sculpher, MJ; Willan, AR; Johnson, RF; Ozdemir, S
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
August 1, 2007
Duke Scholars
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
ISSN
1053-8569
Publication Date
August 1, 2007
Volume
16
Start / End Page
S183 / S183
Publisher
JOHN WILEY & SONS LTD
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lynd, L. D., Colley, L., Najafzedeh, M., Sculpher, M. J., Willan, A. R., Johnson, R. F., & Ozdemir, S. (2007). Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 16, S183–S183.
Lynd, Larry D., Lindsey Colley, Mehdi Najafzedeh, Mark J. Sculpher, Andrew R. Willan, Reed F. Johnson, and Semra Ozdemir. “Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 16 (August 1, 2007): S183–S183.
Lynd LD, Colley L, Najafzedeh M, Sculpher MJ, Willan AR, Johnson RF, et al. Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2007 Aug 1;16:S183–S183.
Lynd, Larry D., et al. “Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 16, JOHN WILEY & SONS LTD, Aug. 2007, pp. S183–S183.
Lynd LD, Colley L, Najafzedeh M, Sculpher MJ, Willan AR, Johnson RF, Ozdemir S. Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. JOHN WILEY & SONS LTD; 2007 Aug 1;16:S183–S183.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
ISSN
1053-8569
Publication Date
August 1, 2007
Volume
16
Start / End Page
S183 / S183
Publisher
JOHN WILEY & SONS LTD
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences